US MedTech: Three Doctors in July: Electrophysiology – Yet More Room for Volume Growth Amongst Key Procedures

Research evidence excerpt

US MedTech: Three Doctors in July: Electrophysiology – Yet More Room for Volume Growth Amongst Key Procedures

Flash |

20 Jul 2026 20:15:44 ET │ 14 pages

US MedTech

Three Doctors in July: Electrophysiology – Yet More Room for Volume

Growth Amongst Key Procedures

CITI'S TAKE

We hosted our final “Three Doctors in July” call with Dr. Mohit Turagam, an

electrophysiologist practicing in New York City. He performs a wide mix of

procedures, notably spending 60% of his time on ablations, 20% on LAAC Joanne WuenschAC

implants, 5% on renal denervation, and the remaining 15% on other device +1-212-816-9606

implants (pacemakers, defibrillators, etc.). Outside of atrial fibrillation (AF, joanne.wuensch@citi.com

up 10-12% in 2026E), he also performs ablations for ventricular Anthony Occhiogrosso

tachycardia (VT, up 5% y/y), premature ventricular contraction (PVC, up +1-212-816-7579

5%), and supraventricular tachycardia (SVT, flattish). Our conversation anthony.occhiogrosso@citi.com

focused on his preference for specific catheters for ablation procedures in

different types of arrythmias, his trends in LAAC implants and takeaways Jane-Marie Lai

from the CHAMPION data, and the ongoing ramp of renal denervation +1-212-816-3628

janemarie.lai@citi.com (RDN) procedures. We come away from the discussion incrementally

positive on the growth outlook of key EP procedures. We rate ABT, BSX, Nikhil Guddeti

JNJ, and MDT Buy. +1-212-816-2606

nikhiltej.guddeti@citi.com

Ablation procedure volumes continue increasing while making use of a broad

toolkit. Dr. Turagam expects to perform ~450 AF cases this year, up from 400 last

year, and increasing to 470-480 next year. All of his AF ablations are done using a

PFA catheter: 40% Medtronic’s Affera Sphere-9, 20% Boston Scientific’s Farapulse,